Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine Academic Article Article uri icon

Overview

MeSH Major

  • Anti-HIV Agents
  • Chemoprevention
  • HIV Infections

abstract

  • Antiretroviral therapy with indinavir, zidovudine, and lamivudine suppressed HIV viremia and produced continued CD4 cell increases in a majority of subjects for 6 years. Most subjects who discontinued study medications had HIV RNA levels suppressed on post-study therapy. Though based on a small group, this study demonstrates the durable effects of antiretroviral therapy.

publication date

  • November 7, 2003

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1097/00002030-200311070-00009

PubMed ID

  • 14571186

Additional Document Info

start page

  • 2345

end page

  • 9

volume

  • 17

number

  • 16